What is Biovigil?
Headquartered in Ann Arbor, MI, BioVigil is at the forefront of hand hygiene technology, offering a patented system designed to elevate hospital compliance rates to 97% and mitigate Healthcare Acquired Infections. The core of their offering is a gentle reminder system that also boosts patient engagement. Central to their value proposition is the BioVigil Data Suite, which furnishes hospitals with actionable insights to refine operational workflows and improve patient care outcomes. The company's focus on data-driven solutions positions it as a key player in the health-tech sector.
How much funding has Biovigil raised?
Biovigil has raised a total of $350K across 1 funding round:
Debt
$350K
Debt (2020): $350K with participation from PPP
Key Investors in Biovigil
PPP
Public-Private Partnership
What's next for Biovigil?
With its substantial backing, Biovigil is poised for accelerated growth and market expansion. The company's large-scale, late-stage funding context suggests a focus on scaling operations, further developing its technology suite, and potentially exploring new market segments. Strategic investments in this phase typically aim to solidify market leadership, enhance competitive advantages, and prepare for future milestones, such as broader adoption across healthcare systems or potential strategic partnerships. The company's trajectory indicates a strong commitment to innovation and impact within the healthcare industry.
See full Biovigil company page
